Home Quinolines 50693-78-2
50693-78-2,MFCD00818513
Catalog No.:AA003LN4

50693-78-2 | 4-Methyl-2-(piperazin-1-yl)quinoline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
1 week  
$340.00   $238.00
- +
1g
1 week  
$484.00   $339.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003LN4
Chemical Name:
4-Methyl-2-(piperazin-1-yl)quinoline
CAS Number:
50693-78-2
Molecular Formula:
C14H17N3
Molecular Weight:
227.3049
MDL Number:
MFCD00818513
SMILES:
Cc1cc(nc2c1cccc2)N1CCNCC1
Properties
Properties
 
BP:
432°C at 760 mmHg  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
250  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
2.4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2014/142114,2014,A1Locationinpatent:Paragraph0477;0478

[2]Solbak,SaraMarieØie;Zang,Jie;Narayanan,Dilip;Høj,LarsJakobsen;Bucciarelli,Saskia;Softley,Charlotte;Meier,Sebastian;Langkilde,AnnetteEva;Gotfredsen,CharlotteHeld;Sattler,Michael;Bach,Anders[JournalofMedicinalChemistry,2020,vol.63,#3,p.1156-1177]

[3]Krahler;Burger[JournaloftheAmericanChemicalSociety,1941,vol.63,p.2367,2370][JournaloftheAmericanChemicalSociety,1942,vol.64,p.2417]

[4]Ulven,Trond;Frimurer,ThomasM.;Receveur,Jean-Marie;Little,PaulBrian;Rist,Øystein;Nørregaard,PiaK.;Högberg,Thomas[JournalofMedicinalChemistry,2005,vol.48,#18,p.5684-5697]

[5]Locationinpatent:experimentalpartAsagarasu,Akira;Matsui,Teruaki;Hayashi,Hiroyuki;Tamaoki,Satoru;Yamauchi,Yukinao;Minato,Kouichi;Sato,Michitaka[JournalofMedicinalChemistry,2010,vol.53,#21,p.7549-7563]

[6]Kubica,KrzysztofP.;Taciak,PrzemysławP.;Czajkowska,Agnieszka;Stokfisz-Ignasiak,Alicja;Wyrebiak,Rafał;Podsadni,Piotr;Młynarczuk-Biały,Izabela;Malejczyk,Jacek;Mazurek,AleksanderP.[Actapoloniaepharmaceutica,2018,vol.75,#4,p.891-901]

[1]Patent:US2003/166637,2003,A1

27914-73-4    50693-78-2   
4-methyl-2-(4-(4-acetoxybenzoyl)-1-piperazinyl)-quinoline 

[1]Kubica,KrzysztofP.;Taciak,PrzemysławP.;Czajkowska,Agnieszka;Stokfisz-Ignasiak,Alicja;Wyrebiak,Rafał;Podsadni,Piotr;Młynarczuk-Biały,Izabela;Malejczyk,Jacek;Mazurek,AleksanderP.[Actapoloniaepharmaceutica,2018,vol.75,#4,p.891-901]

[1]Actapoloniaepharmaceutica,2018,vol.75,p.891-901

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:50693-78-2 Molecular Formula|50693-78-2 MDL|50693-78-2 SMILES|50693-78-2 4-Methyl-2-(piperazin-1-yl)quinoline